Shares of CohBar, Inc. (NASDAQ:CWBR – Get Free Report) rose 4.7% during mid-day trading on Monday . The stock traded as high as $0.51 and last traded at $0.51. Approximately 155 shares were traded during trading, a decline of 93% from the average daily volume of 2,369 shares. The stock had previously closed at $0.49.
CohBar Stock Performance
The firm has a fifty day simple moving average of $0.49 and a 200-day simple moving average of $0.53.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
See Also
- Five stocks we like better than CohBar
- What is the Australian Securities Exchange (ASX)
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Want to Profit on the Downtrend? Downtrends, Explained.
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How to Capture the Benefits of Dividend Increases
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
